Business · 07/07/2020Updated: 10/17/2026 · 1 min read
FDA Submits Proposed Collection of Information for Review Under Paperwork Reduction Act
Summary
The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, focusing on health care providers' understanding of opioid analgesic abuse deterrent formulations.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →